HEИндивидуална стипендия2023–2025

BIOSTAB-DIFF · Controlling cellular differentiation of industrial enzyme production in Bacillus subtilis

„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“

Период: 2023-09-01 → 2025-08-31
Финансиране от ЕС: 203 464 €
Участници: 1
Схема: HORIZON-TMA-MSCA-PF-EF

Линиите свързват координатора с партньорите.

Накратко на български

Бактериите Bacillus subtilis се модифицират генетично, за да се спре процесът на спорулация при производството на индустриални ензими. Това помага за постигане на по-стабилен добив и по-висока продуктивност в биотехнологичните процеси.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Controlling cellular differentiation of industrial enzyme production in Bacillus subtilis

The project BIOSTAB-DIFF (“Controlling cellular differentiation of industrial enzyme production in Bacillus subtilis”) aimed to improve microbial enzyme productivity and stability by addressing bistable sporulation, a process that generates heterogeneous populations and reduces yield consistency in industrial fermentations. The central hypothesis was that blocking sporulation at defined checkpoints, together with nutrient optimization, would stabilize enzyme secretion and enhance productivity. The overall objective was to investigate and control cellular heterogeneity in B. subtilis for biotechnological applications. Specific goals were: (1) to construct and characterize sporulation-deficient strains (ΔspoIIE and ΔsigF), (2) assess the impact of these genetic modifications on growth and fitness, (3) evaluate enzyme production under controlled fermentation conditions, (4) optimize nutrient formulations for maximizing yield and secretion stability, and (5) disseminate findings through publications, presentations, and training.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

To cope with an ever changing environment, bacteria often develop a bet-hedging strategy like bi-stable cellular differentiation, resulting in cell populations with different properties. For example, the industrially relevant model bacterium Bacillus subtilis can become motile, genetically competent, secrete degradative enzymes, or sporulate, and these cellular differentiations can occur simultaneously in a single genetically homogenous population. This cellular heterogeneity exhibited by bacterial cells from the same parent with similar genetic properties is a carefully regulated process that prepares the population for unpredictable environmental stress. Unfortunately, this cellular differentiation can pose serious challenges for the production of enzymes via industrial fermentation, since it means that not all cells in the fermentor are actively involved in enzyme production. This Marie Curie BIOSTAB-DIFF project aims at investigating how enzyme expression differs between individual cells of B. subtilis, and how this cellular heterogeneity can be possibly controlled by genetic interventions. B. subtilis has become a universal microbial cell factory for many industrial products such as enzymes and vitamins. Better enzyme yield would be achieved by reducing cellular heterogeneity in this organism, and that would serve as an asset to the biotech industry. The project will be carried out in the Swammerdam Institute of Life Sciences (SILS) at the University of Amsterdam (UvA), under the supervision of Prof. Leendert Hamoen, one of the leading experts in heterogenic protein expression in the model organism B. subtilis.

Оригинален текст от CORDIS (на английски).

Участници

UNIVERSITEIT VAN AMSTERDAM · AmsterdamКоординаторНидерландия